Why Making Dramatic Moves: WPCS International Incorporated (NASDAQ:WPCS), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), INSYS Therapeutics, Inc.

On 23 February, WPCS International Incorporated (NASDAQ:WPCS) announced that it has entered into a joint go-to-market pilot program, in advance of executing a more formal strategic alliance agreement, with Canada-based technology companies Imaginet Resources Corp. (‘Imaginet’) and Iluminari, Inc. (‘Iluminari Tech’), which will enable WPCS to provide full-turnkey installation and seamless integration of audio-visual systems.

WPCS International Incorporated (NASDAQ:WPCS) belongs to Technology sector. Its net profit margin is -60.10% and weekly performance is 13.93%. On last trading day company shares ended up at $1.39. WPCS International Incorporated (NASDAQ:WPCS) distance from 50-day simple moving average (SMA50) is 5.80%.

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) announced that Isaac Ciechanover, M.D., the Company’s President and Chief Executive Officer, will present at the Cowen and Company 36th Annual Health Care Conference on Monday, March 7, 2016 at 3:20 p.m. ET. The conference will be held at the Boston Marriott Copley Place Hotel in Boston, MA.

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares advanced 7.60% in last trading session and ended the day at $17.69. ATRA return on assets is -23.90%. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) quarterly performance is -55.29%.

On 23 February, INSYS Therapeutics, Inc. (NASDAQ:INSY) reported Revenue from Subsys® (fentanyl sublingual spray) was $91.1 million, up 38% compared with fourth quarter 2014 revenue of $66.1 million; Net income was $17.0 million, or $0.24 per basic and $0.22 per diluted share, compared to net income of $9.3 million, or $0.13 per basic and diluted share, for the fourth quarter of 2014.

On 01 March, INSYS Therapeutics, Inc. (NASDAQ:INSY) shares decreased -0.51% and was closed at $17.39. INSY EPS growth in last 5 year was 17.30%. INSYS Therapeutics, Inc. (NASDAQ:INSY) year to date (YTD) performance is -39.26%.

Gilead Sciences Inc. (NASDAQ:GILD) announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of the company. John F. Milligan, PhD, currently President and Chief Operating Officer, will be promoted to CEO and appointed to the company’s Board of Directors.

Gilead Sciences Inc. (NASDAQ:GILD) ended the last trading day at $89.69. Company weekly volatility is calculated as 2.52% and price to cash ratio as 8.39. Gilead Sciences Inc. (NASDAQ:GILD) showed a weekly performance of 1.52%.

Symantec Corporation (NASDAQ:SYMC) declared a special dividend. Investors of record on Tuesday, March 8th will be paid a dividend of 4.00 per share on Tuesday, March 22nd. This represents a yield of 3.12%. The ex-dividend date of this dividend is Friday, March 4th.

Symantec Corporation (NASDAQ:SYMC) shares moved up 5.02% in last trading session and ended the day at $20.28. SYMC Gross Margin is 82.20% and its return on assets is 5.80%. Symantec Corporation (NASDAQ:SYMC) quarterly performance is 4.79%.

Leave a Reply

Your email address will not be published. Required fields are marked *